CLDF Title
Contact Us | Bookmark
Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
  Liver News - REUTERS   Congress Calendar   Physician Resources  
Rare pregnancy complication linked to non-alcoholic fatty liver disease
Sunday is 'Hepatitis Testing Day'
Reanalysis of tenofovir study changes some findings
Worse outcomes for patients not achieving sustained viral remission after HCV treatment
China seeks loophole as UN nears pact banning toxic chemical - activists
Gilead's NASH drug fails to meet late-stage study goal
Whole exome sequencing shows promise in diagnosing unexplained liver disease
Novo Nordisk and Gilead team up to test fatty liver disease treatment
Clusters of autoimmune liver disease suggest environmental trigger
US liver cancer deaths more common with less education
Fecal microbiome signature detects cirrhosis in nonalcoholic fatty-liver disease
More heart, lung transplants possible with therapy to clear Hep C from donor organs
WHO criteria for chronic hep B miss patients in Ethiopia needing treatment
Aspirin use tied to reduced liver-cancer risk in chronic hepatitis B
View Complete News Library
May 18-22, 2019
AAPA - American Academy of PAs
Denver, CO, USA
May 18-21, 2019
DDW - Digestive Disease Week
San Diego, CA, USA
June 7-8, 2019
SHC - Singapore Hepatology Conference
Suntec, Singapore
June 14-15, 2019
GALA - GI & Liver Association of the Americas
Ft Lauderdale, FL, USA
June 27-29, 2019
ALEH - Latinamerican Association for the Study of the Liver-Congreso Hepato
Recoleta, Argentina
July 20-21, 2019
NCCHC - National Commission on Correctional Health Care
Las Vegas, NV, USA
August 9-10, 2019
Advanced Hepatology Educational Summit for 3rd Year Fellows
Chicago, IL, USA
August 15-18, 2019
NCAD - National Conference on Addiction Disorders- NCAD EAST
Baltimore, MD, USA
September 5-7, 2019
GHAPP - Gastroenterology & Hepatology Advanced Practice Providers
Las Vegas, NV, USA
October 2-6, 2019
IDSA - Infectious Diseases Society of America- ID Week
Washington, DC, USA
October 19-23, 2019
AATOD - American Association for the Treatment of Opioid Dependence
Orlando, FL, USA
View all Congresses
  Featured Abstracts          
Identifying and Treating Nonalcoholic Fatty Liver Disease
Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study
Correlation Between Adiponectin Gene rs1501299 Polymorphism and Nonalcoholic Fatty LiverDisease Susceptibility: A Systematic Review and Meta-Analysis
Health and Economic Burden of Nonalcoholic Fatty Liver Disease in the United States and Its Impact on Veterans
Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times
Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017
Hepatitis B: Screening, Prevention, Diagnosis, and Treatment
Impact of Sofosbuvir-Based Therapy on Liver Transplant Candidates with Hepatitis C Virus Infection
Screening and Treating Hepatitis C in the VA: Achieving Excellence Using Lean and System Redesign
Hepatocellular Carcinoma and Associated Clinical Features in Latino and Caucasian Patients from a Single Center
Patterns and Predictors of Mortality after Waitlist Dropout of Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma
Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
Evidence of bias during liver transplant evaluation of nonalcoholic steatohepatitis cirrhosis patients
NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis
Achieving Excellence in Hepatitis B Virus Care for Veterans in the Veterans Health Administration
Pelvic Floor Dysfunction in the Female Athlete
Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology
Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease
Update on the Management of Hepatitis C Virus Infection in the Setting of Chronic Kidney Disease and Kidney Transplantation
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis CVirus Genotype 1 or 4 Infection and Advanced Kidney Disease
Safety and Efficacy of Elbasvir/Grazoprevir in Asian Participants with Hepatitis CVirus Genotypes 1 and 4 Infection
Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study
OPTN/SRTR 2017 Annual Data Report: Liver
Protective effects of coffee consumption following liver transplantation for hepatocellular carcinoma in cirrhosis
Late-onset Stevens-Johnson syndrome due to nivolumab use for hepatocellular carcinoma
Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond
HCC Immune Surveillance and Antiviral Therapy of Hepatitis C Virus Infection
Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both?
Assessing liver fibrosis without biopsy in patients with HCV or NAFLD
Population Management of Nonalcoholic Fatty Liver Disease
Current treatment options for nonalcoholic fatty liver disease
Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review
Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis
Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers
Short-term budget affordability of hepatitis C treatments for state Medicaid programs
Understanding how, why, for whom, and under what circumstances opt-out blood-borne virus testing programmes work to increase test engagement and uptake within prison: a rapid-realist review
Development and relative validation of a short food frequency questionnaire for assessing dietary intakes of non-alcoholic fatty liver disease patients
Characteristics and outcome of hepatocellular carcinoma in patients with NAFLDwithout cirrhosis
Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease(NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study
An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease(NAFLD) associated with obesity
Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume
Current State of Tumor Ablation Therapies
Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?
What Comes First: Treatment of Viral Hepatitis or Liver Cancer?
Three risk factors for pulmonary metastasectomy in patients with hepatocellular carcinoma
Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis
The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
Hepatitis B and C virus infection as a risk factor for Parkinson
Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation
Maintaining complete virological suppression by reduced doses of nucleos(t)ide analogue in patients with chronic hepatitis B
Fibrosis reversal after hepatitis C virus elimination
Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014-2017
Family Practitioner-Directed Hepatitis C Therapy With Direct-Acting Antivirals Achieves High-Sustained Virologic Response in Prison Population
Increasing access for veterans with hepatitis C by enhancing use of clinical pharmacy specialists
Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver?
MR Imaging: A Personalized approach to understanding fatty liver disease
Sarcopenic obesity in fatty liver
Nonalcoholic Fatty Liver Disease, Male Sexual Dysfunction, and Infertility: Common Links, Common Problems
From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis
Current state-of-the-art pharmacotherapy for the management of hepatitis B infection
Pathophysiology and Treatment of Hepatitis B and C Infections in Patients With End-Stage Renal Disease
Sexual Behaviors and Health Practices Among Student Service Members and Veterans
Multidisciplinary Approach to HCC Management: How Can This Be Done?
The 100 most influential manuscripts on hepatocellular carcinoma: a bibliometric analysis
Role of Exercise in the Management of Hepatic Encephalopathy: Experience From Animal and Human Studies
Plasma Fibroblast Growth Factor 21 is Associated with Severity of Nonalcoholic Steatohepatitis in Patients with Obesity and Type 2 Diabetes
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy
Prognostic Implications of Minimal/Covert Hepatic Encephalopathy: Large-scale Validation Cohort Studies
          View All Abstracts  
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Hepatorenal Syndrome
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
CLDF Sponsors & Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
CLDF Follow Us
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2019 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.